Persevere Therapeutics Inc.
New Filing
CIK: 0002115419·Other·DELAWARE·Filed: Mar 4, 2026
Total Offering
$4,999,999
Amount Sold
$1,574,999
Investors
12
First Sale
Feb 11, 2026
Offering Details
- Type
- Equity
- Exemptions
- Rule 506(b)
- Entity Type
- Corporation
- Year Incorporated
- 2025
- Non-Accredited Investors
- No
Related Persons
| Name | Role |
|---|---|
| Greg Bosch | Related Person |
Company
SEC Filing
0002115419-26-000001
View on SEC EDGARWant deeper insights?
Sign up for free to search all filings, track companies, and set up alerts.
Sign Up Free